Interleukin-6 stimulates coagulation, not fibrinolysis, in humans

Thrombosis and Haemostasis

Volumn 76, Issue 5, 1996, Pages 738-742

  Stouthard, Jacqueline M L ^a   Levi, Marcel ^a   Hack, C Erik ^b   Veenhof, Cees H N ^a   Romijn, Hans A ^a   Sauerwein, Hans P ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; PROTHROMBIN; RECOMBINANT INTERLEUKIN 6; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; FEMALE; FEVER; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY METASTASIS; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RIGOR;

EID: 0029964844     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650653     Document Type: Article

References (33)

1. Marder VJ, Martin SE, Francis CW, Colman RW. Consumptive thrombohemorrhagic disorders. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. J. B. Lippincott Company, Philadelphia, 1987; pp 975-1015.
2. Levi M, ten Cate H, Van der Poll T, Van Deventer SJH. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975-9.
3. Van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, Van Deventer SJH, Hack CE, Sauerwein HP, Rosenberg RD, Ten Cate JW. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622-7.
4. Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989; 74: 165-72.
5. Van der Poll T, Levi M, Büller HR, Van Deventer SJH, De Boer JP, Hack CE, ten Cate JW. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991; 174: 729-32.
6. Silverman P, Goldsmith GH, Spitzer TR, Rehmus EH, Berger NA. Effect of tumor necrosis factor on the human fibrinolytic system. J Clin Oncol 1990; 8: 468-75.
7. van Hinsbergh VWM, Bauer KA, Kooistra T, Kuft C, Dooijeward G, Sherman ML, Nieuwenhuizen W. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. Blood 1990; 76: 2284-9.
8. Logan TH, Virji MA, Gooding WE, Bontempo FA, Ernstoff MS, Kirkwood JM. Plasminogen activator and its inhibitor in cancer patients treated with tumor necrosis factor. J Natl Cancer Inst 1992; 84: 1802-10.
9. Van der Poll T, Levi M, Van Deventer SJH, Ten Cate H, Haagmans BL, Biemond BJ, Büller HR, Hack CE, Ten Cate JW. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 1994; 83: 446-51.
10. Hinshaw LB, Tekamp-Olson P, Chang ACK, Lee PA, Taylor Jr. FB, Murray CK, Peer GT, Emerson Jr. TE, Passey B, Kuo GC. Survival of primates in LDlOO septic shock following therapy with antibody to tumor necrosis factor (TNF). Circ Shock 1990; 30: 279-92.
11. Le J, Vilcek J. Interleukin-6: a multifunctional cytokine regulating immune reactions and the acute phase protein sequence. Lab Invest 1989; 61: 588-602.
12. Van der Poll T, Levi M, Hack CE, Ten Cate H, Van Deventer SJH, Eerenberg AJM, De Groot ER, Jansen J, Gallati H, Büller HR, ten Cate JW, Aarden LA. Elimination of interleukin-6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253-9.
13. Heremans H, Dillen C, Put W, Van Damme J, Billiau A. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels. Eur J Immunol 1992; 22: 2395-401.
14. Helle M, Boeije L, de Groot ER, De Vos A, Aarden LA. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids and sera. J Immunol Methods 1991; 138: 47-56.
15. Van Zonneveld AJ, Veerman H, Brakenhof JP, Aarden LA, Cajot JF, Pannekoek H. Mapping of epitopes on human tissue plasminogen activator with recombinant deletion mutant proteins. Thromb Haemost 1987; 57: 82-6.
16. Levi M, De Boer JP, Roem D, Ten Cate JW, Hack CE. Plasminogen activation in vivo upon intravenous infusion of DDAVP: quantative assessment of plasmin-alpha2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Thromb Haemost 1992; 67: 111-6.
17. De Boer JP, Creasey AA, Chang A, Roem D, Brouwer MC, Eerenberg AJM, Hack CE, Taylor Jr. FB. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. Circ Shock 1993; 39: 59-67.
18. De Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, Lambers JWJ, Van Mourik JA, Hack CE. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines - Evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1991; 65: 181-5.
19. Verheijen HJ, Mullaart E, Chang GTG, Kluft C, Wijnaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurement in plasma. Thromb Haemost 1982; 48: 266-9.
20. Stouthard JML, Van der Poll T, Endert E, Bakker PJM, Veenhof CHN, Sauerwein HP, Romijn JA. The acute and chronic effects of interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 1994; 79: 1342-6.
21. Stouthard JML, Goey H, De Vries EGE, De Mulder PH, Groenewegen A, Pronk L, Stoter G, Sauerwein HP, Bakker PJM, Veenhof CHN. Recombinant humaninterleukin-6 in metastatic renal cell cancer: A phase II trial. Br J Cancer in press.
22. Edwards EL, Rickles FR. The role of leukocytes in the activation of blood coagulation. Semin Hematol 1992; 29: 202-12.
23. Mestries J-C, Kruithof EKO, Gascon M-P, Herodin F, Agay D, Ythier A. In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons. Eur Cytokine Netw 1994; 5: 275-81.
24. Lowry SF, Calvano SE, Van der Poll T. Measurement of inflammatory mediators in clinical sepsis. In: Sibbald WJ, Vincent JL, eds. Clinical trials for the treatment of sepsis. Springer-Verlag, 1995; pp 86-105.
25. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169: 333-8.
26. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MRB. Interleukin-6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surgery 1994; 81: 1306-8.
27. Van Deventer SJH, Büller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990; 76: 2520-6.
28. Taylor Jr. FB, Chang A, Peer G, Li A, Burstein S. IL-6 amplifies the coagulopathic response of the baboon to E. Coli. Thromb Haemost 1995; 73: 1433 (abstract).
29. Levi M, Ten Cate H, Bauer KA, Van der Poll T, Edgington TS, Büller HR, van Deventer SJH, Hack CE, Ten Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifyllin or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114-20.
30. Taylor Jr. FB, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127-34.
31. Creasey AA, Chang ACK, Feigen L, Wün TC, Taylor Jr. FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91: 2850-60.
32. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
33. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg 1992; 79: 757-60.